FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1888464293> ?p ?o ?g. }

• W1888464293 endingPage "e0141896" @default.
• W1888464293 startingPage "e0141896" @default.
• W1888464293 abstract "There is a theoretical risk of adverse events following immunization with a preservative-free, 2-dose vial formulation of 10-valent-pneumococcal conjugate vaccine (PCV10). We set out to measure this risk. Four population-based surveillance sites in Kenya (total annual birth cohort of 11,500 infants) were used to conduct a 2-year post-introduction vaccine safety study of PCV10. Injection-site abscesses occurring within 7 days following vaccine administration were clinically diagnosed in all study sites (passive facility-based surveillance) and, also, detected by caregiver-reported symptoms of swelling plus discharge in two sites (active household-based surveillance). Abscess risk was expressed as the number of abscesses per 100,000 injections and was compared for the second vs first vial dose of PCV10 and for PCV10 vs pentavalent vaccine (comparator). A total of 58,288 PCV10 injections were recorded, including 24,054 and 19,702 identified as first and second vial doses, respectively (14,532 unknown vial dose). The risk ratio for abscess following injection with the second (41 per 100,000) vs first (33 per 100,000) vial dose of PCV10 was 1.22 (95% confidence interval [CI] 0.37–4.06). The comparator vaccine was changed from a 2-dose to 10-dose presentation midway through the study. The matched odds ratios for abscess following PCV10 were 1.00 (95% CI 0.12–8.56) and 0.27 (95% CI 0.14–0.54) when compared to the 2-dose and 10-dose pentavalent vaccine presentations, respectively. In Kenya immunization with PCV10 was not associated with an increased risk of injection site abscess, providing confidence that the vaccine may be safely used in Africa. The relatively higher risk of abscess following the 10-dose presentation of pentavalent vaccine merits further study." @default.
• W1888464293 created "2016-06-24" @default.
• W1888464293 creator A5006529188 @default.
• W1888464293 creator A5008950900 @default.
• W1888464293 creator A5013169634 @default.
• W1888464293 creator A5018969075 @default.
• W1888464293 creator A5020444727 @default.
• W1888464293 creator A5027299180 @default.
• W1888464293 creator A5027864452 @default.
• W1888464293 creator A5031215432 @default.
• W1888464293 creator A5037723243 @default.
• W1888464293 creator A5042587707 @default.
• W1888464293 creator A5047187139 @default.
• W1888464293 creator A5050084765 @default.
• W1888464293 creator A5051218273 @default.
• W1888464293 creator A5052559136 @default.
• W1888464293 creator A5054546284 @default.
• W1888464293 creator A5057576061 @default.
• W1888464293 creator A5057849978 @default.
• W1888464293 creator A5070569884 @default.
• W1888464293 creator A5071480202 @default.
• W1888464293 creator A5073330626 @default.
• W1888464293 creator A5075903729 @default.
• W1888464293 creator A5077054627 @default.
• W1888464293 creator A5079064230 @default.
• W1888464293 creator A5085602093 @default.
• W1888464293 creator A5086245832 @default.
• W1888464293 creator A5088210523 @default.
• W1888464293 date "2015-10-28" @default.
• W1888464293 modified "2023-10-15" @default.
• W1888464293 title "Risk of Injection-Site Abscess among Infants Receiving a Preservative-Free, Two-Dose Vial Formulation of Pneumococcal Conjugate Vaccine in Kenya" @default.
• W1888464293 cites W1988608804 @default.
• W1888464293 cites W2004018788 @default.
• W1888464293 cites W2037336197 @default.
• W1888464293 cites W2037543045 @default.
• W1888464293 cites W2039928243 @default.
• W1888464293 cites W2072858631 @default.
• W1888464293 cites W2089791892 @default.
• W1888464293 cites W2101661555 @default.
• W1888464293 cites W2121369371 @default.
• W1888464293 cites W2151505990 @default.
• W1888464293 doi "https://doi.org/10.1371/journal.pone.0141896" @default.
• W1888464293 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4625023" @default.
• W1888464293 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26509274" @default.
• W1888464293 hasPublicationYear "2015" @default.
• W1888464293 type Work @default.
• W1888464293 sameAs 1888464293 @default.
• W1888464293 citedByCount "7" @default.
• W1888464293 countsByYear W18884642932016 @default.
• W1888464293 countsByYear W18884642932017 @default.
• W1888464293 countsByYear W18884642932019 @default.
• W1888464293 countsByYear W18884642932020 @default.
• W1888464293 countsByYear W18884642932021 @default.
• W1888464293 crossrefType "journal-article" @default.
• W1888464293 hasAuthorship W1888464293A5006529188 @default.
• W1888464293 hasAuthorship W1888464293A5008950900 @default.
• W1888464293 hasAuthorship W1888464293A5013169634 @default.
• W1888464293 hasAuthorship W1888464293A5018969075 @default.
• W1888464293 hasAuthorship W1888464293A5020444727 @default.
• W1888464293 hasAuthorship W1888464293A5027299180 @default.
• W1888464293 hasAuthorship W1888464293A5027864452 @default.
• W1888464293 hasAuthorship W1888464293A5031215432 @default.
• W1888464293 hasAuthorship W1888464293A5037723243 @default.
• W1888464293 hasAuthorship W1888464293A5042587707 @default.
• W1888464293 hasAuthorship W1888464293A5047187139 @default.
• W1888464293 hasAuthorship W1888464293A5050084765 @default.
• W1888464293 hasAuthorship W1888464293A5051218273 @default.
• W1888464293 hasAuthorship W1888464293A5052559136 @default.
• W1888464293 hasAuthorship W1888464293A5054546284 @default.
• W1888464293 hasAuthorship W1888464293A5057576061 @default.
• W1888464293 hasAuthorship W1888464293A5057849978 @default.
• W1888464293 hasAuthorship W1888464293A5070569884 @default.
• W1888464293 hasAuthorship W1888464293A5071480202 @default.
• W1888464293 hasAuthorship W1888464293A5073330626 @default.
• W1888464293 hasAuthorship W1888464293A5075903729 @default.
• W1888464293 hasAuthorship W1888464293A5077054627 @default.
• W1888464293 hasAuthorship W1888464293A5079064230 @default.
• W1888464293 hasAuthorship W1888464293A5085602093 @default.
• W1888464293 hasAuthorship W1888464293A5086245832 @default.
• W1888464293 hasAuthorship W1888464293A5088210523 @default.
• W1888464293 hasBestOaLocation W18884642931 @default.
• W1888464293 hasConcept C126322002 @default.
• W1888464293 hasConcept C141071460 @default.
• W1888464293 hasConcept C147789679 @default.
• W1888464293 hasConcept C156957248 @default.
• W1888464293 hasConcept C185592680 @default.
• W1888464293 hasConcept C2777035434 @default.
• W1888464293 hasConcept C2778866548 @default.
• W1888464293 hasConcept C2781253189 @default.
• W1888464293 hasConcept C2908647359 @default.
• W1888464293 hasConcept C3018125106 @default.
• W1888464293 hasConcept C44249647 @default.
• W1888464293 hasConcept C501593827 @default.
• W1888464293 hasConcept C71924100 @default.
• W1888464293 hasConcept C72092618 @default.
• W1888464293 hasConcept C86803240 @default.
• W1888464293 hasConcept C89423630 @default.
• W1888464293 hasConcept C99454951 @default.

• next